Article
TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma.
Journal of translational medicine - 1 Dec 2023
Zhou Yiran, Jin Jiabin, Ji Yuchen, Zhang Jiaqiang, Fu Ningzhen, Chen Mengmin, Wang Jun, Qin Kai, Jiang Yu, Cheng Dongfeng, Deng Xiaxing, Shen Baiyong
Abstract excerpt
BACKGROUND: Although the molecular features of pancreatic ductal adenocarcinoma (PDAC) have been well described, the impact of detailed gene mutation subtypes on disease progression remained unclear. This study aimed to evaluate the impact of different TP53 mutation subtypes on clinical characteristics and outcomes of patients with PDAC. METHODS: We included 639 patients treated with PDAC in Ruijin Hospital...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
